HIV dynamics: Modeling, data analysis, and optimal treatment protocols

Journal of Computational and Applied Mathematics

Volumn 184, Issue 1, 2005, Pages 10-49

  Adams, B M ^a   Banks, H T ^a   Davidian, M ^a   Kwon, Hee Dae ^a,c   Tran, H T ^a   Wynne, S N ^a   Rosenberg, E S ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Inha University   (South Korea)

Author keywords

Data and model reduction; HIV models; Optimal control; Parameter estimation; Structured treatment interruptions

Indexed keywords

COMPUTER SIMULATION; CONTROL THEORY; DATA REDUCTION; DISEASES; IMMUNOLOGY; INVERSE PROBLEMS; MATHEMATICAL MODELS; OPTIMAL CONTROL SYSTEMS; PARAMETER ESTIMATION; PATHOLOGY; SENSITIVITY ANALYSIS; STATISTICAL METHODS;

HIV MODELS; INFECTION; PATHOGENESIS; STRUCTURED TREATMENT INTERRUPTIONS;

VIRUSES;

EID: 23344442942     PISSN: 03770427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cam.2005.02.004     Document Type: Article

References (70)

1. B.M. Adams, H.T. Banks, J.E. Banks, J.D. Stark, Population dynamics models in plant-insect herbivore-pesticide interactions, CRSC Technical Report CRSC-TR03-12, NCSU, Raleigh, March, 2003 (revised August, 2003; Math. Biosci., to appear).
2. C.A. Andrews J.M. Davies G.R. Schwarz Adaptive data compression Proc. IEEE 55 1967 267-277
3. N. Aubry P. Holmes J.L. Lumley E. Stone The dynamics of coherent structures in the wall region of a turbulent boundary layer J. Fluid Mech. 192 1988 115-173
4. H.T. Banks, D.M. Bortz, A parameter sensitivity methodology in the context of HIV delay equation models, CRSC Technical Report CRSC-TR02-24, NCSU, Raleigh, August, 2002 (J. Math. Biol., to appear).
5. H.T. Banks, D.M. Bortz, S.E. Holte, Incorporation of uncertainty in mathematical modeling of HIV infection dynamics, CRSC Technical Report CRSC-TR01-25, NCSU, Raleigh, September, 2001 (Math. Biosci. 183 (2003) 63-91).
6. H.T. Banks, N.L. Gibson, W.P. Winfree, Electromagnetic crack detection inverse problems using terahertz interrogating signals, CRSC Technical Report CRSC-TR03-40, NCSU, Raleigh, October, 2003.
7. G. Berkooz P. Holmes J.L. Lumley J.C. Mattingly Low-dimensional models of coherent structures in turbulence Phys. Rep. 287 1997 338-384
8. S. Bonhoeffer J.M. Coffin M.A. Nowak Human immunodeficiency virus drug therapy and virus load J. Virol. 97 1997 3275-3278
9. S. Bonhoeffer M. Rembiszewski G.M. Ortiz D.F. Nixon Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection AIDS 14 2000 2313-2322
10. P. Borrow H. Lewicki B. Hahn G.M. Shaw M.B. Oldstone Virus-specific CD8+ cytotoxic T-lymphocyte activity asssociated with control of viremia in primary human immunodeficiency virus type 1 infection J. Virol. 68 1994
11. M.E. Brandt B. Chen Feedback control of a biodynamical model of HIV-1 IEEE Trans. Biomed. Eng. 48 2001 754-759
12. R.P. Bucy Immune clearance of HIV type 1 replication-active cells: a model of two patterns of steady state HIV infection Aids Res. Hum. Retr. 15 1999 223-227
13. K.P. Burnham D.R. Anderson Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach 2002 Springer New York
14. S. Butler D. Kirschner S. Lenhart Optimal control of the chemotherapy affecting the infectivity of HIV O. Arino D. Axelrod M. Kimmel Advances in Mathematical Population Dynamics-Molecules, Cells and Man 1997 Word Scientific Press Singapore 557-569
15. D.S. Callaway A.S. Perelson HIV-1 infection and low steady state viral loads Bull. Math. Biol. 64 2001 29-64
16. M. Dalod et al. Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8+ responses in HIV type 1-infected patients: Comparison with anti-epstein-barr virus responses and changes during anti-retroviral therapy J. Virol. 73 1999 7108-7116
17. M. Davidian D.M. Giltinan Nonlinear Models for Repeated Measurement Data 1995 Chapman & Hall London
18. R.T. Davey N. Bhat C. Yoder et al. HIV-1 and T cell dynamics after interruption of highly active anti-retroviral therapy (HAART) in patients with a history of sustained viral suppression Proc. Natl. Acad. Sci. 96 1999 15109-15114
19. C.A. Derdeyn J.M. Kilby G.D. Miralles L.F. Li G. Sfakianos M.S. Saag R.D. Hockett R.P. Bucy Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type-1-infected subjects in the absence or presence of efffective therapy J. Inf. Dis. 180 1999 1851-1862
20. M. Eslami Theory of Sensitivity in Dynamic Systems 1994 Springer Heidelberg
21. K.R. Fister S. Lenhart J.S. McNally Optimizing chemotherapy in an HIV model Electr. J. Differential Equations 32 1998 1-12
22. W.H. Fleming R.W. Rishel Deterministic and Stochastic Optimal Control 1975 Springer New York
23. P.M. Frank Introduction to System Sensitivity Theory 1978 Academic Press New York
24. F. Garcia M. Plana C. Vidal et al. Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy AIDS 13 1999 F79-F86
25. R.C. Gonzalez P.A. Wintz Digital Image Processing 1987 Addison-Wesley Reading, MA
26. C.M. Gray et al. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individual receiving highly active anti-retroviral therapy (HAART) J. Immunol. 62 1999 1780-1788
27. M.D. Gunzburger Perspectives in Flow Control and Optimization 2003 SIAM Philadelphia
28. P.A. Haslett D.F. Nixon Z. Shen et al. Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy J. Inf. Dis. 181 2000 1264-1272
29. R. Hilai J. Rubinstein Recognition of rotated images by invariant Karhunen-Loève expansion J. Opt. Soc. Amer. A-Opt. Image Sci. Vis. 11 1994 1610-1618
30. D.D. Ho A.U. Neumann A.S. Perelson et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature 373 1995 123-126
31. I.T. Jolliffe Principal Component Analysis 1986 Springer New York
32. H.R. Joshi Optimal control of an HIV immunology model Optim. Contr. Appl. Math. 23 2002 199-213
33. S.A. Kalams et al. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active anti-retroviral therapy J. Virol. 73 1999 6721-6728
34. M.I. Kamien N.L. Schwartz Dynamic Optimization 1991 North-Holland Amsterdam
35. M. Kirby L. Sirovich Application of the Karhunen-Loève procedure for the characterization of human faces IEEE Trans. Pattern Anal. Mach. Intell. 12 1990 103-108
36. D. Kirschner S. Lenhart S. Serbin Optimal control of the chemotherapy of HIV J. Math. Biol. 35 1997 775-792
37. J. Lisziewicz F. Lori Structured treatment interruptions in HIV/ AIDS therapy Microbes Infect. 4 2002 207-214
38. J. Lisziewicz E. Rosenberg J. Liebermann Control of HIV despite the discontinuation of anti-retroviral therapy New Engl. J. Med. 340 1999 1683-1684
39. M. Loève Probability Theory 1955 van Nostrand Princeton, NJ
40. D.L. Lukes Differential Equations: Classical to Controlled, Mathematics in Science and Engineering 1982 Academic Press New York
41. J.L. Lumley The structure of inhomogeneous turbulent flows A.M. Yaglom V.I. Tatarski Atmospheric Turbulence and Radio Wave Propagation 1967 Nauka Moscow 166-178
42. K. Luzuriaga et al. Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants J. Virol. 73 1999 362-367
43. H.V. Ly H.T. Tran Modeling and control of physical processes using proper orthogonal decomposition Math. Comp. Model. 33 2001 223-236
44. A.J. Melvin et al. HIV-1 dynamics in children AIDS 20 1999 468-473
45. J.E. Mittler B. Sulzer A.U. Neumann A.S. Perelson Influence of delayed viral production on viral dynamics in HIV-1 infected patients Math. Biosci. 152 1998 143-163
46. A.U. Neumann R. Tubiana V. Calvez C. Robert T.S. Li H. Agut B. Autran HIV-1 rebound during interruption of highly active anti-retroviral therapy has no deleterious effect on re-initiated treatment AIDS 13 1999 677-683
47. D.W. Notermans J. Goudsmit S.A. Danner Rate of HIV-1 decline following anti-retroviral therapy is related to viral load at baseline and drug regimen AIDS 12 1998 1483-1490
48. M.A. Nowak C.R. Bangham Population dynamics of immune responses to persistent viruses Science 272 1996 74-79
49. G.S. Ogg et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA Science 279 1998 2103-2106
50. G.S. Ogg et al. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination anti-retroviral therapy J. Virol. 73 1999 797-800
51. G. Ortiz D. Nixon A. Trkola et al. HIV-1 specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active anti-retroviral therapy J. Clin. Invest. 104 1999 R13-R18
52. A. Oxenius et al. Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ lymphocytes Proc. Natl. Acad. Sci. 97 2000 3382-3387
53. E. Papasavvas G.M. Ortiz R. Gross et al. Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption J. Inf. Dis. 182 2000 766-775
54. A.S. Perelson A.U. Essunger P.Y. Cao et al. Decay characteristics of HIV-1 infected compartments during combination therapy Nature 387 1997 188-191
55. A.S. Perelson P.W. Nelson Mathematical analysis of HIV-1 dynamics in vivo SIAM Rev. 41 1999 3-44
56. A.S. Perelson A.U. Neumann M. Markowitz et al. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time Science 271 1996 1582-1586
57. C.J. Pitcher C. Quittner D.M. Peterson et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression Nature Med. 5 1999 518-525
58. E.S. Rosenberg M. Altfeld S.H. Poon et al. Immune control of HIV-1 after early treatment of acute infection Nature 407 2000 523-526
59. L. Ruiz, Martünez-Picado, J. Romeu, et al., Structured Ztreatment interruption in chronically HIV-1 infected patients after long-term viral suppression, AIDS 14 (2000) 397-403.
60. J.E. Schmitz et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes Science 283 1999 857-860
61. L. Sirovich Turbulence and the dynamics of coherent structures, Part II: Symmetries and transformations Quart. Appl. Math. XLV 1987 573-582
62. H.M. Speigel et al. Changes in frequency of HIV-1 specific cytotoxic T cell precursors and circulating effectors after combination anti-retroviral therapy in children J. Inf. Dis. 180 1999 359-368
63. A.A. Tsiatis V. DeGruttola M.S. Wulfsohn Modeling the relationship of survival to longitudinal data measured with error: Applications to survival and CD4 counts in patients with AIDS J. Amer. Stat. Assoc. 90 1995 27-37
64. P.J.E. Vermeulen D.P. Casasent Karhunen-Loève techniques for optimal processing of time-sequential imagery Opt. Eng. 30 1991 415-423
65. S. Watanabe, Karhunen-Loève expansion and factor analysis theoretical remarks and applications, in: Proceedings of the 4th Prague Conf. Inform. Theory, 1965.
66. X. Wei S.K. Ghosh M.E. Taylor et al. Viral dynamics of HIV-1 infection Nature 373 1995 117-122
67. L.M. Wein S.A. Zenios M.A. Nowak Dynamic multidrug therapies for HIV: A control theoretic approach J. Theor. Biol. 185 1997 15-29
68. D. Wodarz M.A. Nowak Specific therapy regimes could lead to long-term immunological control of HIV Proc. Natl. Acad. Sci. 96 1999 14464-14469
69. H. Wu A.A. Ding Population HIV-1 dynamics in vivo: Applicable models and inferential tools for virological data from AIDS clinical trials Biometrics 55 1999 410-418
70. H. Wu, et. al. Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination anti-retroviral therapy: Relationships to host factors, cellular restoration, and virologic end points J. Inf. Dis. 179 1999 799-807